Abstract:This brief review highlights new studies in three areas of the GH field, namely diagnostics, therapeutics and biomarkers. The diagnosis of GH deficiency has always presented a challenge: there is no "gold standard" test of GH status, and GH levels during stimulation testing are affected by many factors that limit diagnostic accuracy. Two new approaches to diagnosis have been proposed: one involves a classical endocrine test of GH production using a GH secretagogue to test the Ghrelin axis, and shows promise in the diagnosis of adult GH deficiency. The other uses a completely different approach analysing the individual's gene expression profile as a surrogate for GH status with high levels of test accuracy. From the therapeutic aspect, there have been significant efforts to produce a long-acting (LA) GH on the premise that this will improve adherence and patient convenience. Aspects of LA-GH pharmacology are considered, and it will be interesting to see in future years what place LA-GH GH takes in the market. Long term surveillance is a vital part of therapeutics; recent studies across Europe have provided reassurance on the safety of recombinant human GH (r-hGH) for those with uncomplicated growth disorders, but do emphasise the need to continue observation through adulthood. The search for biomarkers that precisely reflect GH action in children and adults is an ongoing task. One of the newer bone markers that shows promise is a fragment of collagen type X which now requires further investigation in humans. In parallel with the diagnostic studies, gene expression profiles at the start of r-hGH treatment have been used to predict GH response in children with GHD and girls with Turner syndrome. These data are promising but need evaluation across a range of growth disorders. R-hGH is an effective, safe therapy used in both children and adults. There is however a need to continue to refine diagnosis, treatment and most importantly long-term pharmacovigilance to ensure that the right patients have the best treatment with robust safety profiles.

An improved reporter gene assay for evaluating the biological activity of recombinant human growth hormone

In Vivo Bioassay of Recombinant Human Growth Hormone Synthesized Inb. Moripupae

Development of a Novel Reporter Gene Assay for Platelet-Derived Growth Factor-Bb Bioactivity.

Clinical Evaluation of Recombinant Human Growth Hormone Injection in Children with Growth Hormone Deficiency

A Cell-Based Strategy for Bioactivity Determination of Long-Acting Fc-Fusion Recombinant Human Growth Hormone

Long-Term Efficacy and Safety of Recombinant Human Growth Hormone in Children Born Small for Gestational Age.

High-level secretory expression, purification and characterization of Ailuropoda melanoleuca growth hormone in Pichia pastoris.

Evaluating the utility of human glucagon-like peptide 1 receptor gene as a novel radionuclide reporter gene: a promising molecular imaging tool

Development and validation of a novel reporter gene assay for determination of recombinant human thrombopoietin

Expression, Purification, And Lipolytic Activity Of Recombinant Human Serum Albumin Fusion Proteins With One Domain Of Human Growth Hormone In Pichia Pastoris

Structural Basis for Activation of the Growth Hormone-Releasing Hormone Receptor.

Recent Advances in the Biological Function of Ghrelin

A Reporter Gene Assay for Determining the Biological Activity of Therapeutic Antibodies Targeting TIGIT

Pharmacokinetics of Recombinant Human Growth Hormone (rhGH) in Beagles by ELISA

Two years in growth hormone 2017-18

RNAe in a transgenic growth hormone mouse model shows potential for use in gene therapy

High-Level Soluble Expression of Higf-1 Fusion Protein in Recombinant Escherichia Coli

In vitro pharmacological characterization of growth hormone secretagogue receptor ligands using the dynamic mass redistribution and calcium mobilization assays

A Superlong‐acting Growth Hormone‐polypeptide Fusion for Growth Hormone Deficiency Treatment

Usefulness and Potential Pitfalls of Long-Acting Growth Hormone Analogs

In vivo and in vitro evidence for growth hormone-like bioactivity of Rhizoma Anemarrhenae extract